SCHEMBL8225877

SCHEMBL8225877

CCC(C)C(=O)c1cnccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
NAPRT Q6XQN6 1/20 0.50
HCAR2 Q8TDS4 1/20 0.50
ADORA3 P0DMS8 1/20 0.48
TSHR P16473 1/20 0.48
MC4R P32245 1/20 0.48
ADRA1A P35348 1/20 0.48
MC3R P41968 1/20 0.48
HTT P42858 2/20 0.48
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
LONP1 P36776 1/20 0.44
RECQL P46063 1/20 0.44
CYP2D6 P10635 1/20 0.44
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1911567 0.81 KDM4E (0.57) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL28787572 0.80 BAZ2B (0.46) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL20705826 0.78 KDM4E (0.53) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL2632671 0.77 KDM4E (0.58) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL11529414 0.77 SMN1; SMN2 (0.48) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL6187789 0.76 KDM4E (0.57) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL11529880 0.76 NPC1 (0.47) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL3400596 0.76 NPC1 (0.47) KDM4ENAPRTHCAR2ADORA3TSHR
SCHEMBL19578168 0.75 GSK3B (0.58) KDM4ENAPRTHTTLMNASMN1; SMN2
SCHEMBL24998246 0.75 KDM4E (0.52) KDM4ENAPRTHCAR2ADORA3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008033460-A2 TREATING PAIN, DIABETES, AND LIPID METABOLISM DISORDERS SCHERING CORPORATION (US) 2008-03-20 WO disclosed
WO-2008033456-A1 SPIRO-CONDENSED AZETIDINE DERIVATIVES USEFUL IN TREATING PAIN, DIABETES AND DISORDERS OF LIPID METABILISM SCHERING CORPORATION (US) 2008-03-20 WO disclosed